BIOMAT Database Logo BIOMAT Database Logo

Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. 1995

I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Division of Gastroenterology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

OBJECTIVE Eradication of Helicobacter pylori infections in humans results in the healing of gastritis and gastric ulcers. This study used a mouse model to test whether oral vaccination can cure Helicobacter infection and gastritis. METHODS Mice were infected with Helicobacter felis. Three weeks after infection, the mice were orally immunized with H. pylori urease B subunit. Control mice were simultaneously infected but sham immunized. RESULTS Three to 8 weeks after oral immunization of H. felis-infected mice with recombinant H. pylori urease B subunit, the infection cleared and there was no evidence of gastritis. Vaccinated mice remained protected against two consecutive H. felis challenges. CONCLUSIONS These results show that the lack of natural immunity against Helicobacter can be overcome by oral immunization and that vaccination offers a novel therapeutic approach to Helicobacter-induced gastritis.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014510 Urease An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5. Phytourease,Urea Amidohydrolase,Amidohydrolase, Urea
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
October 2002, Chinese medical journal,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Systemic immunization with urease protects mice against Helicobacter pylori infection.
May 1998, Vaccine,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
October 2005, The Journal of infectious diseases,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.
October 1994, Gastroenterology,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
December 2005, Biomedical and environmental sciences : BES,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
August 2009, FEMS immunology and medical microbiology,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
March 2020, Vaccine,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection.
January 2005, Vaccine,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
March 1999, Vaccine,
I Corthésy-Theulaz, and N Porta, and M Glauser, and E Saraga, and A C Vaney, and R Haas, and J P Kraehenbuhl, and A L Blum, and P Michetti
Evaluating the immune responses of mice to subcutaneous immunization with Helicobacter pylori urease B subunit.
February 2014, Journal of animal science and biotechnology,
Copied contents to your clipboard!